Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Can B Corp

Healthcare US CANB

NoneUSD
0.00(0%)

Last update at 2025-10-16T20:13:19.337015Z

Day Range

--
LowHigh

52 Week Range

0.00310.18
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap2.12M
  • VolumeNone
  • P/E Ratio0.31
  • Dividend Yield-%
  • EBITDA-6.77503M
  • Revenue TTM1.03M
  • Revenue Per Share TTM0.02
  • Gross Profit TTM -0.34331M
  • Diluted EPS TTM0.09

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -14.92338M -12.16832M -5.71321M -4.59039M -4.11228M
Minority interest - - - - 0.00000M
Net income -14.92417M -12.16939M -5.71651M -4.59247M -4.11228M
Selling general administrative 13.54M - 4.61M 5.80M 3.59M
Selling and marketing expenses - - 0.52M 0.33M 0.08M
Gross profit 2.61M 2.99M 1.43M 1.71M 0.26M
Reconciled depreciation 1.43M 0.54M 0.78M 0.23M 0.00547M
Ebit -14.16815M -10.26601M -4.36441M -4.58412M -4.14053M
Ebitda -12.74029M -9.72067M -3.58111M -4.34972M -4.13506M
Depreciation and amortization 1.43M 0.55M 0.78M 0.23M 0.00547M
Non operating income net other - - -0.40718M - 0.00000M
Operating income -14.16815M -10.26601M -4.36441M -4.58412M -3.41577M
Other operating expenses 20.85M 14.87M 6.07M 6.89M 4.08M
Interest expense 0.90M 2.10M 0.93M 0.00879M 0.26M
Tax provision 0.00079M 0.00108M 0.00330M 0.00208M 0.00000M
Interest income - - - 0.00252M 0.01M
Net interest income -0.90213M -2.10219M -0.93468M -0.00627M -0.25318M
Extraordinary items - - - - 0.00000M
Non recurring - - - - 0.00000M
Other items - - - - 0.00000M
Income tax expense 0.00079M 0.00108M 0.00330M 0.00208M -0.43299M
Total revenue 6.69M 4.60M 1.71M 2.31M 0.67M
Total operating expenses 16.78M 13.26M 5.80M 6.29M 3.68M
Cost of revenue 4.07M 1.61M 0.28M 0.60M 0.41M
Total other income expense net -0.75523M -1.90231M -1.34880M -0.00627M -0.44332M
Discontinued operations - - - - 0.00000M
Net income from continuing ops -14.92417M -12.16939M -5.71651M -4.59247M -4.11228M
Net income applicable to common shares -14.92417M -12.16939M -5.71651M -5.90076M -4.11228M
Preferred stock and other adjustments - - - - 0.00000M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 10.13M 15.56M 16.47M 5.69M 6.93M
Intangible assets 0.10M 0.11M 0.37M 0.52M 1.06M
Earning assets - - - - -
Other current assets 0.00414M 0.02M 0.00162M 1.21M 1.28M
Total liab 11.13M 12.86M 10.86M 2.44M 0.56M
Total stockholder equity -1.00197M 2.70M 5.62M 3.26M 6.37M
Deferred long term liab - - - - -
Other current liab 0.36M 0.68M 2.63M 0.20M 0.21M
Common stock 83.26M 79.61M 49.68M 26.11M 23.11M
Capital stock 91.60M 87.84M 78.32M 31.65M 28.65M
Retained earnings -102.42830M -92.69083M -77.76666M -30.38602M -23.36122M
Other liab - - - - -
Good will - - - 0.06M 0.06M
Other assets 0.00000M 0.18M 0.18M 0.04M 1.26M
Cash 0.03M 0.07M 0.45M 0.46M 0.05M
Cash and equivalents - - - - -
Total current liabilities 11.13M 12.42M 9.46M 2.23M 0.51M
Current deferred revenue - - - - -
Net debt 8.79M 8.97M 6.62M 1.62M 0.09M
Short term debt 8.82M 8.60M 5.67M 1.87M 0.07M
Short long term debt 8.57M 7.95M 4.87M 1.83M 0.04M
Short long term debt total 8.82M 9.04M 7.07M 2.08M 0.13M
Other stockholder equity 9.82M 7.55M 5.06M 1.99M 1.08M
Property plant equipment - 6.57M 9.27M 0.99M 1.17M
Total current assets 5.38M 8.70M 6.65M 4.02M 3.39M
Long term investments - - - - -
Net tangible assets - -5.62926M -23.39650M -2.28333M -0.28538M
Short term investments - - - - -
Net receivables 3.72M 6.59M 3.65M 2.01M 1.28M
Long term debt - - - 0.19M -
Inventory 1.62M 2.02M 2.55M 0.34M 0.78M
Accounts payable 1.95M 3.14M 1.16M 0.15M 0.23M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.12M - - - -0.12283M
Additional paid in capital - - - - -
Common stock total equity - - - 26.11M -
Preferred stock total equity - - - 5.54M -
Retained earnings total equity - - - -30.38602M -
Treasury stock - - - -0.57268M -
Accumulated amortization - - - - -
Non currrent assets other 0.25M 0.18M 0.18M 0.04M 1.26M
Deferred long term asset charges - - - - -
Non current assets total 4.75M 6.86M 9.82M 1.67M 3.54M
Capital lease obligations 0.25M 1.09M 2.20M 0.06M 0.10M
Long term debt total - - - 0.19M -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 0.00000M -0.86079M -0.02525M -1.66028M -0.04598M
Change to liabilities 1.99M 1.66M -0.07283M 0.15M -0.11524M
Total cashflows from investing activities - -0.86079M -0.02525M -1.66028M -0.04598M
Net borrowings 3.15M 1.62M 2.64M 0.02M 0.03M
Total cash from financing activities 3.57M 8.17M 2.38M 3.31M 1.61M
Change to operating activities -0.51692M 0.45M 0.04M 0.13M 0.09M
Net income -14.92417M -12.16939M -5.71651M -4.59247M -4.11228M
Change in cash -0.37581M -0.00880M 0.41M -0.76121M 0.81M
Begin period cash flow 0.45M 0.46M 0.05M 0.81M 0.00165M
End period cash flow 0.07M 0.45M 0.46M 0.05M 0.81M
Total cash from operating activities -3.94742M -7.32273M -1.94709M -2.41342M -0.75357M
Issuance of capital stock 0.50M 6.56M 0.30M 3.30M 1.57M
Depreciation 1.43M 0.54M 0.78M 0.23M 0.00547M
Other cashflows from investing activities - -0.14450M 0.02M -0.00488M -0.00488M
Dividends paid - -1.75000M -4.52162M - 0.00000M
Change to inventory 0.53M -2.20848M 0.93M -0.20989M 0.00238M
Change to account receivables -3.69056M -1.70501M -1.02237M -1.46592M -0.03310M
Sale purchase of stock 1.75M 1.75M -0.56000M - 0.00000M
Other cashflows from financing activities 1.70M 1.84M 8.53M 0.04M 0.88M
Change to netincome 10.79M 4.46M 2.91M 4.64M 3.22M
Capital expenditures 0.00000M 0.72M 0.05M 1.66M 0.05M
Change receivables - - -0.96440M - 0.00000M
Cash flows other operating - - 0.43M - 0.00000M
Exchange rate changes - - - - 0.00000M
Cash and cash equivalents changes - - 0.41M - 0.00000M
Change in working capital -1.68939M -1.79837M -0.12140M -1.39549M -0.05988M
Stock based compensation 5.06M 2.40M 2.26M 3.09M 2.78M
Other non cash items 6.17M 3.84M 0.73M 0.25M 2.22M
Free cash flow -3.94742M -8.03903M -1.99731M -4.06882M -0.79995M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CANB
Can B Corp		 - -% - 0.31 8.85 2.05 33.49 18.68 -2.1662
ZTS
Zoetis Inc		 1.20 1.57% 77.59 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 0.58 1.91% 31.01 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 - -% 153.91 21.73 14.95 3.16 2.15 3.56 12.82
GALDY
GALDERMA GROUP AG		 -0.79 1.89% 40.92 74.21 41.67 8.64 5.55 9.15 42.22

Reports Covered

Stock Research & News

View All

Profile

Can B Corp. develops, manufactures, and sells hemp biomass derived products containing cannabinoids. The company provides hemp cannabinoid products, including oils, creams, moisturizers, isolate, gel caps, spa products, concentrates, and lifestyle products. It sells its products under the Canbiola and Pure Leaf Oil brands through medical professionals under distribution agreements and its website. The company also produces industrial hemp, and processes hemp biomass, isolate, and isomers, such as CBN, CBG, delta-8, and delta-10; and manufactures and sells durable medical equipment. The company was formerly known as Canbiola Inc. and changed its name to Can B Corp. in January 2020. Can B Corp. was incorporated in 2005 and is based in Hicksville, New York.

Can B Corp

960 South Broadway, Hicksville, NY, United States, 11801

Key Executives

Name Title Year Born
Mr. Marco Alfonsi Chairman & CEO 1961
Mr. Stanley L. Teeple CFO, Sec. & Director 1952
Mr. Philip P. Scala Interim Chief Operating Officer 1951
Mr. Pasquale Ferro Pres of Pure Health Products 1961
Mr. Greg Partin Chief Information Officer NA
Mr. Andrew W. Holtmeyer VP of Bus. Devel. 1961
Steven Apolant Pres of Green Grow Farms, Inc. NA
Mr. Stanley L. Teeple CFO, Secretary & Director 1952
Mr. Pasquale Ferro President of Pure Health Products LLC 1961
Mr. Andrew W. Holtmeyer Vice President of Business Development 1961

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions